
ChemoCentryx CCXI
Quartalsbericht 2022-Q2
hinzugefügt 08.08.2022
ChemoCentryx PEG 2011-2026 | CCXI
PEG Jährlich ChemoCentryx
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -0 | -4.74 | 1.45 | 0.0531 | 0.183 | -0.408 | 2.73 | 0.554 | -0.428 | 0.0131 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.73 | -4.74 | -0.0591 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Celldex Therapeutics
CLDX
|
1.27 | $ 34.99 | 3.35 % | $ 2.32 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 4.36 | 9.92 % | $ 10.5 B | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Citius Pharmaceuticals
CTXR
|
-0.00125 | $ 0.88 | 2.99 % | $ 5.92 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
Akari Therapeutics, Plc
AKTX
|
13.5 | $ 5.52 | 7.71 % | $ 372 B | ||
|
Aligos Therapeutics
ALGS
|
0.0282 | $ 6.66 | -13.05 % | $ 65.8 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 309.33 | -3.37 % | $ 40.5 B | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Forte Biosciences
FBRX
|
0.00783 | $ 32.91 | 4.71 % | $ 426 M | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Galectin Therapeutics
GALT
|
0.235 | $ 2.47 | 9.29 % | $ 158 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 22.62 | 3.71 % | $ 1.06 B | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 104.72 | 2.55 % | $ 27.2 B | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Galapagos NV
GLPG
|
0.0003 | $ 29.25 | 1.35 % | $ 2.69 B | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Grifols, S.A.
GRFS
|
-0.077 | $ 8.73 | 1.54 % | $ 6.83 B | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
GT Biopharma
GTBP
|
-0.00067 | $ 0.38 | -3.91 % | $ 2.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.04 | -1.3 % | $ 5 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
BioXcel Therapeutics
BTAI
|
-0.000761 | $ 1.19 | 10.75 % | $ 14.5 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Hoth Therapeutics
HOTH
|
-0.00188 | $ 0.72 | -3.12 % | $ 9.94 M | ||
|
Akebia Therapeutics
AKBA
|
1.02 | $ 1.44 | 6.65 % | $ 370 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Harmony Biosciences Holdings
HRMY
|
0.631 | $ 30.25 | 2.82 % | $ 1.74 B | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.37 | 2.58 % | $ 467 M | ||
|
InflaRx N.V.
IFRX
|
0.094 | $ 1.56 | 29.91 % | $ 152 M | ||
|
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | ||
|
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 24.77 | 2.4 % | $ 3.15 B | ||
|
Burford Capital Limited
BUR
|
-0.568 | $ 4.97 | 6.32 % | $ 792 M | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
Immutep Limited
IMMP
|
1.57 | $ 0.59 | 1.79 % | $ 1.08 B | ||
|
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | ||
|
Cabaletta Bio
CABA
|
-0.01 | $ 3.41 | -3.12 % | $ 343 M |